NeoOncovac vaccine shows positive results in first melanoma patient

NeoOncovac melanoma treatment mRNA cancer vaccine Gamaleya Research Institute personalized immunotherapy

The first patient treated with the personalized Russian cancer vaccine, NeoOncovac, has shown significant positive results. Alexander Gintsburg, scientific director of the Gamaleya Research Institute, reported that the patient, a 60-year-old man with stage-three melanoma, has seen his metastases disappear and has recorded no new tumor growth during a four-month observation period.

The vaccine utilizes mRNA technology to create a customized treatment based on the specific genetic profile of a patient's tumor. This approach trains the immune system to identify and destroy malignant cells while sparing healthy tissue. The treatment was developed through a collaboration between the Gamaleya Center and the National Medical Research Center of Radiology.

To date, six patients have received the vaccine. A second patient is currently halfway through a ten-dose course and has tolerated the treatment well without side effects like fever. Researchers aim to include 20 patients in the treatment process by the end of the year. The patient will remain under monthly medical supervision for three years to monitor for potential recurrence.

Entities

Aleksandr Gintsburg · Alexander Gintsburg · Andrei Kaprin · Andrey Kaprin · Gamaleya National Research Center for Epidemiology and Microbiology · Gamaleya Research Institute · National Medical Research Center for Radiology · National Medical Research Center of Radiology · Neooncovac · Neoonkovak

Claims

What the coverage asserts, and how many sources carry each claim.

[● 6 SOURCES] Researchers plan to include 20 patients in the treatment process by the end of the year. www.rtvslon.ba · ciudadbqto.com · radio580.com.ni · canal6.com.ni · afamily.vn · +1 more
[● 5 SOURCES] The patient is a 60-year-old man from the Kursk region with melanoma. plusinfo.mk · www.rtvslon.ba · afamily.vn · giaoducthoidai.vn · rt-english.com
[● 14 SOURCES] The vaccine is developed through a collaboration between the Gamaleya Center and the National Medical Research Center of Radiology. bigportal.ba · atvbl.rs · gradskeinfo.rs · radio580.com.ni · canal6.com.ni · +9 more
[● 15 SOURCES] The first patient treated with the NeoOncovac vaccine has seen their metastases disappear. bigportal.ba · plusinfo.mk · atvbl.rs · lat.sputnikportal.rs · www.rtvslon.ba · +10 more
[● 15 SOURCES] The NeoOncovac vaccine uses mRNA technology. bigportal.ba · plusinfo.mk · atvbl.rs · www.rtvslon.ba · ciudadbqto.com · +10 more
[● 14 SOURCES] The patient will be monitored monthly for three years. bigportal.ba · plusinfo.mk · atvbl.rs · www.rtvslon.ba · ciudadbqto.com · +9 more
[● 8 SOURCES] Six patients have received the vaccine so far. www.rtvslon.ba · ciudadbqto.com · radio580.com.ni · canal6.com.ni · rt-english.com · +3 more
[● 15 SOURCES] No new tumors have been detected in the patient during a four-month observation period. bigportal.ba · plusinfo.mk · www.rtvslon.ba · ciudadbqto.com · radio580.com.ni · +10 more